VIN-CENT WUHu, Ya-HuiYa-HuiHuWu, Che-HsiungChe-HsiungWuKao, Chih-ChinChih-ChinKaoWang, Cheng-YiCheng-YiWangYang, Wei-ShenWei-ShenYangLee, Hsiu-HaoHsiu-HaoLeeChang, Yuan-ShianYuan-ShianChangChen, LikwangLikwangChenSHUO-MENG WANGYEN-HUNG LINKWAN-DUN WUSHIH-CHIEH CHUEH2021-08-022021-08-022014-1008954356https://scholars.lib.ntu.edu.tw/handle/123456789/575650To develop algorithms of locating patients with primary aldosteronism (PA) using insurance reimbursement data and to validate the algorithms using medical charts.enAdjudication; Administrative data; Medical chart review; Mineralocorticoid receptor antagonist; Primary aldosteronism; Validation[SDGs]SDG3aldosterone; mineralocorticoid antagonist; potassium; prescription drug; renin; mineralocorticoid antagonist; adult; Article; controlled study; data extraction; diagnostic accuracy; diagnostic test accuracy study; essential hypertension; feasibility study; female; high risk patient; hospital patient; human; ICD-9-CM; length of stay; major clinical study; male; medical record review; national health insurance; outpatient care; patient identification; prescription; primary hyperaldosteronism; reimbursement; sensitivity and specificity; systolic blood pressure; Taiwan; aged; algorithm; hyperaldosteronism; medical record; middle aged; prescription; reproducibility; statistics and numerical data; Adult; Aged; Algorithms; Drug Prescriptions; Female; Humans; Hyperaldosteronism; Insurance, Health, Reimbursement; Male; Medical Records; Middle Aged; Mineralocorticoid Receptor Antagonists; Reproducibility of Results; Taiwanjournal article10.1016/j.jclinepi.2014.05.012250341962-s2.0-84908238093